Norges Bank Purchases New Position in Sabra Healthcare REIT, Inc. $SBRA

Norges Bank acquired a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 3,059,387 shares of the real estate investment trust’s stock, valued at approximately $57,945,000. Norges Bank owned about 1.23% of Sabra Healthcare REIT at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Rothschild Investment LLC boosted its position in shares of Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares in the last quarter. Founders Capital Management bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at $28,000. Strengthening Families & Communities LLC bought a new stake in shares of Sabra Healthcare REIT in the 4th quarter valued at $29,000. Danske Bank A S acquired a new stake in Sabra Healthcare REIT during the 3rd quarter worth $30,000. Finally, Larson Financial Group LLC raised its stake in Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 553 shares during the period. Institutional investors own 99.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Monday, May 18th. UBS Group boosted their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Wednesday, May 13th. Cantor Fitzgerald raised their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Finally, Citizens Jmp lifted their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research note on Wednesday, February 18th. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $22.40.

Sabra Healthcare REIT Price Performance

SBRA stock opened at $18.46 on Monday. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. The stock has a market capitalization of $4.66 billion, a P/E ratio of 29.30, a P/E/G ratio of 1.39 and a beta of 0.64. The business has a 50-day moving average of $20.15 and a 200-day moving average of $19.69. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.17 and a fifty-two week high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. The business had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.Sabra Healthcare REIT’s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.